On 18 July 2013, GSK invited key opinion leaders in the field of dentistry and the press to the storied venue of the Royal Institution of Great Britain, London, to share with them the story behind NovaMin®.
Stephen Hancocks, the Editor-in-Chief of the British Dental Journal, opened the evening, handing over firstly to Dr Teresa Layer from GSK and secondly to David Greenspan Ph.D. co-inventor of NovaMin®.
Dr Teresa Layer Vice-President of Oral Health Research & Development at GSK
Dr Layer told the story of Sensodyne and NovaMin®:
GSK and secondly to David Greenspan Ph.D. co-inventor of NovaMin®.
David Greenspan Ph.D the co-inventor of NovaMin with over 34 years of experience in the medical device industry.
David gave an in-depth account of the science behind the ingredient:
References: 1. Burwell A et al. J Clin Dent 2010; 21 (Spec Iss): 66-71. 2. Efflandt SE et al. J Mater Sci: Mater Med 2002; 13 (6): 557-565. 3. Earl JS et al. J Clin Dent 2011; 22 (Spec Iss): 68-73. 4. Parkinson CR & Willson RJ. J Clin Dent 2011; 22 (Spec Iss): 74-81. 5. Wang Z et al. S Dent 2010; 38: 400-410. 6. LaTorre G, Greenspan DC. J Clin Dent 2010; 21 (Spec Iss): 72-76. 7. Earl JS et al. J Clin Dent 2011; 22 (Spec Iss): 62-67. 8. Du MQ et al. Am J Dent 2008; 21 (4): 210-214. 9. Salian S et al. J Clin Dent 2010; 21 (Spec Iss): 82-87. 10. Pradeep AR & Sharma A. J Periodontol 2010; 81 (8): 1167-1173.
When patients suffer from dentine hypersensitivity, as a dental professional...Read more
Participate in the oral care distance learner modules, free online modules which can contribute up to 1.5 hours of CPD for each module!For other resources click here